diabetes Track

Our Diabetes Track will look at the evolution of diabetes care, particularly how medical technology has improved the management and monitoring of the condition. From the advent of CGM’s to the impact of GLP-1 on the medical device industry, this track will discuss not only how technology is treating diabetes but the potential to reverse the root causes of the disease. 

We’ll begin with a focus on technology that enables the measurement of the disease. In our second session, we’ll discuss inpatient interventions that treat the progression of the disease including surgery solutions. During our last panel, we’ll discuss how medical technology can improve the ongoing maintenance of the disease, as well as proactively reduce complications.


  1. Measurement Tech

1:00 – 1:45 PM

Yael Glassman
Vice President of Business Development and Strategy, Diabetes, Medtronic

2. Interventional Tech

2:00 – 3:00 PM

Joe Virgillo
CEO, Morphic Medical

Stacey Pugh
CEO, Endogenex

3. Management Tech

3:15 – 4:00 PM

Jon Bloom, MD
CEO, Podimetrics

Trang Ly, MBBS, FRACP, PhD
Senior Vice President and Medical Director, Insulet Corporation